Global Comprehensive Synthetic Biology Markets Rep

Dublin, March 09, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Synthetic Biology: Global Markets" report to their offering. Report Includes: - An overview of the global markets for synthetic biology. - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021. - Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells - Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics - Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture - Analysis of the synthetic biology industry structure, competitors and intellectual property landscape - An assessment of the products and technologies most commercially viable in the immediate and near-future time frame. - Profiles of major players in the industry The study scope includes core synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, genome editing, bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years. We analyze key synthetic-biology technologies and products to determine present and future market status, and forecasted growth from 2016 through 2021. We also discuss strategic alliances, industry structures, competitive dynamics, patents and market driving forces. The synthetic-biology industry is examined by market segment, including the following segments: DNA sequencing; DNA synthesis; genome editing; synthetic-biology foundries; industrial biotechnology; pharmaceuticals; and agriculture. The role of key strategic alliances and acquisitions from 2014 through 2016 is discussed.

Emerging markets including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops, chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 135 companies in these fields are highlighted. Key Topics Covered: 1: Introduction - Study Goals And Objectives - Reasons For Doing The Study - Contribution Of The Study And For Whom - Scope And Format - Methodology - Information Sources 2: Summary 3: Overview - Synthetic-Biology Technologies Covered In This Report - What Is Synthetic Biology? - Development Stage Of Synthetic Biology - Forces Driving Synthetic-Biology Market Growth - Global Markets For Synthetic-Biology Products - Life-Cycle Status Of Products And Technologies - Synthetic-Biology Industry 4: Synthetic-Biology Technologies - Introduction - Synthetic-Biology Technology Overview - Enabling Technologies - Biologic Components And Integrated Systems Technologies - Enabled Technologies - Pathway Engineering - Research And Development Applications - Biofuels Technologies 5: Synthetic-Biology Applications - Enabling Technologies Applications - Biologic Components And Integrated Systems Applications - Enabled Products Applications 6: Synthetic-Biology Industry - Industrial Biotechnology Value Chain - Industry Structural Forces - Products And Technology Life Cycle - Dna-Sequencing Instrument Industry - Third-Generation Sequencing Industry - Oligonucleotide Synthesis Industry - Gene-Synthesis Industry - Genome-Editing Tools Industry - Synthetic-Biology Foundries Industry - Pharmaceuticals Industry - Agriculture Industry - Acquisitions And Strategic Alliances 7: Synthetic-Biology Markets - Industry Growth-Driving Forces - Synthetic-Biology Markets By End-User Industry - Synthetic-Biology Market By Product Type - Enabled Products Market - Regional Markets 8: Patents - Introduction - Foundational Patents - Synthetic-Biology Industry Patent Analysis - Genome Editing - Crispr/Cas9 Patent Landscape 9: Company Profiles - 20N Labs Inc. - Abeona Therapeutics Inc. - Active Motif - Agilis Biotherapeutics Llc - Agrivida - Algenuity - Ambrx Inc. - Amyris Inc. - Araknitek - Arzeda Corp. - Astrazeneca Plc - ATG Biosynthetics GMBH - Atum - Avidbiotics Corp. - BASF AG - Bayer AG - Beta Renewables - Bioamber Inc. - Bio Basic Canada Inc. - Biomax Informatics AG - Bioneer Corp. - Bio S&T Inc. - Bluebird Bio - Blue Marble Biomaterials - Bolt Threads - British Petroleum - Bristol-Myers Squibb - Calysta Inc. - Cargill Inc. - Caribou Biosciences Inc. - Cell Design Labs - Cellectis SA - Chain Biotechnology Ltd - Cibus Inc. - Codexis Inc. - Demuris Limited - Desktop Genetics Ltd. - DOW Chemical Company - E.I. Du Pont De Nemours And Company - Dyadic International Inc. - Editas Medicine Inc. - Enbiotix Inc. - Enevolv Inc. - Epoch Life Science Inc. - Eurofins Mwg Operon - Evolva SA - Evonetix - Exxonmobil Corp. - Gen9 Inc. - Genemed Synthesis Inc. - Gene Oracle Inc. - Geneworks Pty. Ltd. - Genomatica - Genscript - Gevo Inc. - Ginkgo Bioworks - Glaxosmithkline Plc - Global Bioenergies - Glycos Biotechnologies Inc. - Goodyear Tire & Rubber Co. - Green Biologics Ltd. - Helix Nanotechnologies Inc. - Illumina Inc. - Industrial Microbes Inc. - Ingenza Ltd. - Inovio Pharmaceuticals Inc. - Integrated Dna Technologies Inc. - Intellia Therapeutics - International Business Machines - Intrexon Corp. - Joule Unlimited - Juno Therapeutics Inc. - Labgenius Ltd. - Lanzatech - Lattice Automation Inc. - Lc Sciences - Lygos Inc. - Merck & Co. - Metabolix Inc. - Michelin Sa - Microsoft Corp. - Modular Genetics Inc. - Morphosys AG - Myriant Technologies Llc - New England Biolabs - Novartis Pharma AG - Novozymes A/S - Omega Bio-Tek Inc. - Oragenics Inc. - Origene Technologies Inc. - Pacific Biosciences Of California Inc. - Pfizer Inc. - Phylogica Limited - Phytowelt Green Technologies GMBH - Precision Biosciences - Prokarium Holdings Ltd. - Qteros Inc. - Radiant Genomics Inc. - Rennovia Inc. - Roosterbio Inc. - Royal DSM NV - Sample6 Technologies - Sangamo Therapeutics Inc. - Sanofi-Aventis - Scarab Genomics Llc - Sea6 Energy Pvt Ltd. - Sgi-Dna Inc. - Shanghai Generay Biotech Co. Ltd. - Shanghai Shinegene Molecular Bio-Technologies Inc. - Sigma Aldrich Corp. - Silicolife Lda. - Soligenix Inc. - Spiber Inc. - Synlogic - Synpromics Ltd. - Synthace Ltd. - Synthetic Biologics Inc. - Synthetic Genomics Inc. - Synthorx Inc. - Synvitrobio Inc. - Taxa Bio-Engineering - Teewinot Life Sciences Corp. - Terravia Holdings Inc. - Teselagen Biotechnology Inc. - Thermo Fisher Scientific Inc. - Touchlight Genetics Ltd - Transcriptic Inc. - Triton Algae Innovations Ltd. - Twist Bioscience - Verdezyne Inc. - Ziopharm Oncology Inc. - Zymergen For more information about this report visit http://www.researchandmarkets.com/research/g2pbqf/synthetic

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Biotechnology